Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)

Inclusion Criteria

• •Patients with CHB diagnosis and no co-infection with Hep A, Hep C, Hep D, or HIV
• •Age 16 years or older
• •No post-transplant patients
• •RCT, non-randomized trials, prospective cohort studies, prospectively analyses case series published since 2003
• •At least one arm of trial must include monotherapy with entecavir, lamivudine, tenofovir, adefovir, or telbivudine
• •Study arms must include at least 10 patients
• •Follow-up of at least 48 weeks
• •Published results available in English language